Along with gaining insights into how to tap into the expertise of cord blood banks and access therapy-matched cord blood units (CBUs), you’ll get a better understanding of:
- Comprehensive benefits of cord blood as an allogeneic cell source for cellular therapy
- Characteristics and attributes of the existing cord blood inventory
- Importance of managing logistics for delivery of CBUs from the bank to the cell therapy developer
- Alternative banking and attribute models that may be needed in the future to support novel therapies
PANELISTS
Heather Stefanski, MD, PhD
Vice President of Medical Services
NMDP℠
Marcie Finney, MBA
Executive Director
Cleveland Cord Blood Center
Christina Melief, PhD
Senior Scientific Program Advisor
NMDP
Ana Valverde, MBA
Administrative Director
Carolinas Cord Blood Bank